We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CRBP market cap is 390.87M. The company's latest EPS is USD -4.2507 and P/E is -8.76.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.18M | -15.8M | -17.3M | -8.19M | -9.49M |
| Net Income | -8.78M | -10.88M | -17.75M | -8.78M | -10.05M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36.14M | 3.94M | 882k | 0 | 0 |
| Operating Income | -77.1M | -122.81M | -55.99M | -39.84M | -45.08M |
| Net Income | -71.45M | -111.27M | -45.64M | -42.35M | -44.6M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 73.83M | 66.31M | 51.65M | 43.72M | 36.28M |
| Total Liabilities | 31.89M | 33.32M | 35.19M | 34.2M | 35.97M |
| Total Equity | 41.95M | 32.99M | 16.46M | 9.52M | 311k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 49.14M | 102.3M | 107.73M | 66.31M | 28.27M |
| Total Liabilities | 42.98M | 57.02M | 38.62M | 33.32M | 35.18M |
| Total Equity | 6.16M | 45.28M | 69.11M | 32.99M | -6.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.09M | -37.54M | -15.12M | -22.92M | -30.09M |
| Investing | 18.29M | 30.07M | 5.55M | 14.36M | 25.25M |
| Financing | -768k | -534k | -113k | -95k | -916k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.72M | -99.69M | -48.18M | -37.54M | -36.1M |
| Investing | -2.74M | -485k | -73.42M | 30.07M | 35.64M |
| Financing | 38.47M | 154.88M | 60.82M | -534k | -2.82M |
| Market Cap | 390.87M |
| Price to Earnings Ratio | -8.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 28.48 |
| Price to Book Ratio | -56.61 |
| Dividend Yield | - |
| Shares Outstanding | 10.49M |
| Average Volume (1 week) | 150.09k |
| Average Volume (1 Month) | 222.56k |
| 52 Week Change | 324.26% |
| 52 Week High | 49.8699 |
| 52 Week Low | 3.0334 |
| Spread (Intraday) | 5.6 (14.74%) |
| Company Name | Corbus Pharmaceuticals Holdings Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.corbuspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
